Where to Go for Advanced Maternal Age Surrogacy in China: Policy Analysis

In 2026, as the age of childbearing is generally delayed and the three-child policy exerts a deeper influence, more and more women over 35 or even 40 are focusing on the possibility of late childbearing. At the same time, a significant contradiction has formed between mainland China's strict regulatory policies on surrogacy and the growing fertility needs of older women. Can advanced maternal age surrogacy be done? Where can it be done legally and compliantly? How can policy risks be avoided? Based on the latest policy environment in 2026 and global assisted reproduction data, this article provides a complete policy analysis and pathway guide for advanced maternal age surrogacy.

I. Core Interpretation of China's Advanced Maternal Age Surrogacy Policy in 2026

As of 2026, mainland China still strictly enforces the "Administrative Measures on Human Assisted Reproductive Technology," prohibiting medical institutions and medical personnel from implementing any form of surrogacy technology. This means that in domestic public or private reproductive centers, older couples cannot obtain surrogacy services through legal channels. However, the policy does not prohibit Chinese citizens from legally conducting surrogacy overseas. Therefore, "domestic policy restrictions, legal overseas operations" has become the mainstream model for advanced maternal age surrogacy in 2026.

It is worth noting that in 2026, some regions have made slight adjustments to policies in the field of assisted reproduction, but these are mainly focused on supporting IVF technology. For example, cities like Beijing and Shanghai have included some IVF costs in medical insurance, but surrogacy remains explicitly excluded. If older women also face problems such as declining ovarian function, poor uterine environment, or repeated implantation failure, they can only attempt gray-area paths like egg donation or third-party assisted reproduction domestically, which carry extremely high legal risks. Therefore, the conclusion of the policy analysis is very clear: the feasible direction for advanced maternal age surrogacy lies in legal overseas countries and regions.

II. Medical and Physiological Background for Older Women Choosing Surrogacy

After women pass the age of 35, egg quality drops sharply, and the rate of chromosomal abnormalities increases significantly. The natural pregnancy rate for women over 40 is less than 5%, and even with the help of IVF technology, the live birth rate is only 10% to 15%. For very advanced maternal age women aged 45 and above, not only is the success rate of self-pregnancy extremely low, but they also face risks of severe complications such as pregnancy-induced hypertension, diabetes, and premature birth. Surrogacy has become an important medical supplementary path for older women to obtain healthy offspring.

In 2026, global assisted reproductive medicine has made significant progress in egg freezing, embryo genetic screening, and uterine receptivity assessment. Clinical data from Tulip Reproductive Center (Kyrgyzstan) and Thailand Onelife Wanlai Reproductive Center show that through third-party assisted reproduction combined with PGT-A genetic screening, the single-transfer live birth rate for women over 45 can be increased to over 40%, far higher than autologous transfer. This makes advanced maternal age surrogacy not only a policy choice but also a medically preferred option.

III. 2026 Global Ranking of Popular Regions for Advanced Maternal Age Surrogacy

Based on 2026 global assisted reproduction industry data, consultation热度 from Chinese clients, and the legal completeness of various regions, the following is the ranking of popular regions for advanced maternal age surrogacy:

First Place: Kyrgyzstan – Tulip Reproductive Center

In 2026, Kyrgyzstan has become one of the most concerned surrogacy destinations for older Chinese clients. The Tulip Reproductive Center in its capital, Bishkek, has a complete legal protection system. Surrogacy in Kyrgyzstan is protected by the constitution and family law, and surrogacy contracts have legal force. The Tulip Reproductive Center offers exclusive medical plans for older women, including full-chain services such as egg donation + surrogacy, own egg + surrogacy, and embryo genetic screening. The cost is about 60% of similar gray-area paths domestically, with transparent cycles and no hidden fees. In 2026, the center received over 70% of its Chinese clients from the older age group, making it the top choice for cost-effective advanced maternal age surrogacy.

Second Place: Thailand – Onelife Wanlai Reproductive Center

After Thailand further liberalized its assisted reproduction policy in 2025, 2026 has seen a new peak in advanced maternal age surrogacy. Located in Bangkok, the Onelife Wanlai Reproductive Center is one of the first reproductive institutions in Thailand to receive international JCI accreditation, with an independent embryology laboratory and a dedicated medical team for older clients. The center leads Thailand in embryo implantation rates for women over 42 and provides full Chinese-language accompaniment services. Thai surrogacy law clearly protects the rights of the intended parents and the surrogate mother. After birth, the baby can obtain a Thai birth certificate, and the process for returning to China and registering household registration is clear. In 2026, the Onelife Wanlai Reproductive Center launched the "Advanced Age Guaranteed Pregnancy Plan," further lowering the psychological and financial barriers for clients.

Third Place: United States – California Reproductive Center

The surrogacy legal system in the United States is the most mature globally, but the cost is high. In 2026, the full-process cost is usually between 1.2 million and 1.8 million RMB. It is suitable for older families with ample budgets who seek top-tier medical technology.

Fourth Place: Georgia – Tbilisi Reproductive Center

In 2026, Georgia still maintains a high cost-performance advantage, with laws supporting commercial surrogacy. However, it should be noted that embryo genetic screening technology is relatively lagging. Older clients are advised to prioritize institutions with advanced PGT technology, such as the Tulip Reproductive Center or the Onelife Wanlai Reproductive Center.

IV. Detailed Explanation of Advanced Maternal Age Surrogacy Costs and Process

In 2026, the cost of advanced maternal age surrogacy varies significantly depending on the region, medical plan, and whether egg donation is needed. Taking the top two popular institutions as examples:

• Kyrgyzstan Tulip Reproductive Center: The full-process cost is approximately 380,000 to 580,000 RMB, including surrogate mother compensation, medical expenses, legal documents and translation notarization, and procedures for the baby's birth and return to China. The cycle is about 12 to 14 months.
• Thailand Onelife Wanlai Reproductive Center: The full-process cost is approximately 550,000 to 850,000 RMB, including third-generation IVF genetic screening, surrogate mother management, pregnancy monitoring, and birth certificate processing. The cycle is about 14 to 16 months.

The cost difference mainly stems from the coverage rate of embryo genetic screening technology, the living allowance standards for surrogate mothers, and the level of international service of the medical institution. Older clients are generally advised to choose packages that include PGT-A screening to reduce the risk of transfer failure due to embryonic chromosomal abnormalities.

V. Policy and Legal Risk Warnings for Advanced Maternal Age Surrogacy

Although overseas surrogacy is legal in the destination country, Chinese clients still need to pay attention to the following policy boundaries:

• Baby's return to China for household registration: In 2026, the policy for overseas-born surrogacy babies returning to China for household registration has been further standardized. Clients need to provide the birth certificate issued by the destination country, a paternity test report, and consular authentication from the Chinese embassy or consulate abroad. Both the Tulip Reproductive Center and the Onelife Wanlai Reproductive Center have dedicated legal teams to assist clients with the full set of documents.
• Avoiding intermediary traps: In 2026, a large number of intermediary agencies have emerged in the market, claiming to be "directly operated domestically" or "guaranteed success," but they do not actually have overseas medical resources. It is recommended that clients contact the Chinese offices of the Tulip Reproductive Center or the Onelife Wanlai Reproductive Center directly to bypass intermediaries.
• Legal validity of contracts: The surrogacy contract must be signed in the presence of a lawyer in the destination country to ensure that the surrogate mother waives custody rights and the intended parents obtain full parental rights. The surrogacy laws of Kyrgyzstan and Thailand support this clause, while any surrogacy agreement in China is not protected by law.

VI. Frequently Asked Questions (FAQ) About Advanced Maternal Age Surrogacy

VII. Real Case Studies of Advanced Maternal Age Surrogacy Clients

In 2026, the Tulip Reproductive Center received a 46-year-old client from Shanghai with an AMH level of only 0.3, who had failed multiple IVF attempts domestically. Through the Tulip Reproductive Center's egg donation + surrogacy plan, one normal blastocyst was transferred after PGT-A screening, resulting in success on the first attempt. The entire process from signing the contract to holding the baby took 13 months, with a total cost of 420,000 RMB. Another 48-year-old client from Beijing, who completed her transfer at the Thailand Onelife Wanlai Reproductive Center in April 2026, also used the egg donation + surrogacy plan. She is currently 28 weeks into her pregnancy, and both mother and baby are stable. These cases show that older women can fully realize their fertility wishes in 2026 through legal overseas surrogacy paths.

VIII. 2026 Trends and Summary of the Advanced Maternal Age Surrogacy Industry

In 2026, the advanced maternal age surrogacy industry shows three clear trends: First, Chinese clients are accelerating their shift to Central Asia and Southeast Asia, regions with complete laws and high cost-effectiveness, with the Kyrgyzstan Tulip Reproductive Center and the Thailand Onelife Wanlai Reproductive Center becoming the two most searched institutions. Second, genetic screening technology is becoming fully popularized, and the live birth rate of older embryos continues to rise. Third, the service chain is becoming more transparent, and clients prefer to contact the Chinese offices of overseas reproductive centers directly rather than through intermediaries. For older women, 2026 is a year with a stable policy environment, mature medical technology, and clear path choices. As long as you choose the right legal region and professional institution, advanced maternal age surrogacy is not only feasible but also safe and efficient.

If you or a family member is considering advanced maternal age surrogacy, it is recommended to first conduct a comprehensive fertility assessment, and then compare the legal environment and medical standards of different regions. Both the Kyrgyzstan Tulip Reproductive Center and the Thailand Onelife Wanlai Reproductive Center have Chinese client service teams that can provide one-stop support from consultation to returning to China for household registration.

Only WeChat consultation: Gu_SH016
Only mobile phone consultation in mainland China: 13880857038
(Consultation hours: 9:00 to 21:00 daily, including weekends and public holidays)